CapitalStars Financial Research Pvt Ltd

CapitalStars

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Monday 26 February 2018

Capitalstars Updates: Dr Reddy's receives unfavourable EIR for its Srikakulam plant: 26 Feb 2018

Capitalstars Updates: Dr Reddy's


The company has launched gRenvela from this site while gCopaxone has also been filed from this site.

Dr Reddy’s has announced that the company has received an unfavorable Established Inspection Report (EIR) for its API facility in Srikakulam. The EIR mentions of OAI (official action indicated) meaning that company will have to provide more details to the USFDA. This means that the plant will continue to remain under the warning letter and one has to see the next course of the action by USFDA.

The OAI is issued when there are objectionable conditions found at the manufacturing facility.

The company has indicated that the company continues to market drugs in the US markets despite the warning letter, however, it has implications for the future drug approvals. Srikakulam plant has two dosages i.e. oral solid and topicals. The company has launched gRenvela from this site while gCopaxone has also been filed from this site.

The company in November 2015 received a warning letter for its two API facilities located at Miryalaguda and Srikakulam and a formulation facility at Duvvada. Of this, Miryalaguda API plant has been cleared after successful re-inspection, while Duvvada formulations and Srikakulam API facility remain under the warning letter.

In April 2017 re-inspection, API facility in Srikakulam received two observations by the US drug regulator. These observations were in the areas of high-performance liquid chromatography (‘HPLC’) maintenance and the management of soft copies of chromatograms. In the warning letter, USFDA had also found previously undisclosed quality-control lab at the facility.

This is a negative news on the counter.


Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us. 


Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

1 comments:

  1. #Stock Tips For The Beginner Investor
    http://www.sooperarticles.com/finance-articles/investing-articles/stock-tips-beginner-investor-1638429.html

    ReplyDelete